India Looks To Model New Central Drug Authority After FDA
This article was originally published in The Pink Sheet Daily
Executive Summary
“The goal is to ensure that any drug approved in India should directly be approved by the U.S. FDA,” health minister says.
You may also be interested in...
India’s Drug Watchdog Speeds Up Regulatory Overhaul
Single window drug clearance, replacing at lest six government departments, to precede central drug authority.
India’s Drug Watchdog Speeds Up Regulatory Overhaul
Single window drug clearance, replacing at lest six government departments, to precede central drug authority.
Booming Clinical Research Business Could Trigger Regulatory Overhaul In India
Indian contract research market may hit $300 million by 2010, U.S. pharma exec says.